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Abstract—Wearable ‘smart patches’ of the future will 
incorporate microneedle technologies that painlessly interact 
with the body, using closed-loop theranostic systems to 
continuously monitor the physiological status of the body and 
deliver appropriate therapeutic agents when needed.  Among 
other components, these Micro Transdermal Interface 
Platforms (MicroTIPs) will require embedded sensors to verify 
that the patch is operating as intended.  
In this paper, we integrate hollow microneedles with 
miniaturized pressure and impedance sensors to create an 
inline sensor subsystem suitable for integration with such a 
smart patch. Preliminary experimental work using an ex-vivo 
skin model shows that the sensors are capable of detecting 
microneedle skin insertion and removal, and of monitoring 
fluidic pressure and detecting leaks during the delivery phase. 
Keywords—Microneedles, transdermal, bioMEMS, 
MicroTIPs 
I.  INTRODUCTION 
In recent years there has been considerable interest in the 
development of microneedle technologies to overcome the 
skin’s stratum corneum (SC) barrier in an accurate and 
minimally invasive manner. This outermost layer of the body 
is just 10-20µm thick and is largely made up of dead, 
keratin-filled cells (corneocytes) embedded in a lipid bilayer 
in a manner somewhat analogous to a bricks and mortar 
arrangement. The stratum corneum regulates water loss from 
the body and also acts as a barrier against external 
contaminants and environmental influences. However, it also 
presents a major impediment to the transdermal delivery of 
therapeutic agents, meaning that drug delivery via the skin is 
currently limited to a small number of low dose (~10 
mg/day), low molecular weight (<500 Da), high lipophilicity 
drugs such as nicotine, scopolamine, testosterone, and 
fentanyl [1]. The stratum corneum layer also has a 
remarkably high resistance to the flow of electrical current. 
Many diagnostic procedures and therapies such as 
physiological signal monitoring or electroporation rely on 
external skin electrodes for the transfer of electrical signals 
or stimuli either to or from the body, and the high impedance 
of the stratum corneum greatly reduces the efficacy of such 
procedures [2]. 
Microneedle arrays are short (typically < 1000 µm in 
height), sharp columnar projections, made from a variety of 
materials and micromanufacturing processes and used for  
drug and vaccine delivery [3-5], physiological signal 
monitoring [6], and diagnostics [7, 8]. Notably, the relatively 
short length of microneedle arrays means that they do not 
stimulate nerve endings that lie deeper in the epidermis, and 
their use is therefore perceived as painless by the patient [9]. 
Microneedle technologies will eventually form the basis 
for wearable, intelligent, patch-like systems, capable of 
independently diagnosing physiological conditions and 
autonomously delivering relevant therapeutic doses, while 
simultaneously relaying patient-centric information to 
clinical personnel using secure wireless protocols.  
These closed loop systems, which we now refer to as 
Micro Transdermal Interface Platforms (MicroTIPs), will 
have significant applications in areas such as diabetes 
management, stress monitoring, Parkinson’s treatment and 
cardiac health, as well as in consumer-orientated areas such 
as high-performance sport and wearable wellness 
monitoring. MicroTIPs will be high-value and complex 
systems, and will lie at the opposite end of the microneedle 
technology spectrum to the low-cost disposable patches 
currently being developed for areas such as vaccine delivery 
[10]. 
MicroTIPs will require key ‘building blocks’ in the form 
of microneedle-based delivery and diagnostics modules that 
will be in direct contact with the body, as well as ancillary 
subsystems for power management, wireless 
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communications and performance validation and control. All 
of these must be integrated and packaged in a flexible, 
comfortable, and unobtrusive form factor. Significant 
miniaturization of communications components, battery 
technology and energy harvesting techniques is required to 
achieve this goal, as are advancements in flexible packaging 
formats, heterogeneous system integration, and micropump 
capabilities. A concept system is shown in Fig. 1. 
 
Fig. 1. Concept diagram of a future Micro Transdermal Interface Platform 
(MicroTIP) constructed and packaged in a wearable ‘smart patch’ format.  
This paper concentrates on one subsystem of these 
platforms, which will fulfill the requirement that MicroTIPS 
be capable of internal validation and self-analysis of system 
operation and performance. It is envisaged that embedded 
sensors will monitor the operational parameters of the 
MicroTIPs patch, ensuring, for example, that the system is 
performing as programmed (e.g. correct delivery dosages 
and flowrates are achieved), that the microneedle arrays are 
correctly embedded in the skin and that no blockages are 
present, that successful therapeutic delivery and uptake has 
occurred, and that patient compliance targets are met. 
In this work, it is shown that by using miniature pressure 
and impedance sensors interfaced to hollow silicon 
microneedle arrays, we can simultaneously monitor both the 
system pressure (thereby detecting leaks and/or blockages), 
and the quality of the skin-array contact (thereby ensuring 
correct application/wear and assessing patient compliance). 
A schematic of the prototype sensor module is shown in Fig. 
2 and is intended for heterogeneous integration within a 
larger platform such as that illustrated in Fig. 1.  
 
Fig. 2. Schematic of embedded sensor module for MicroTIPs.  
This initial demonstrator has been validated in ex-vivo 
human skin models in a laboratory setting, and represents the 
first step towards an intelligent, self-regulating transdermal 
delivery system. 
II. EXPERIMENTAL DETAILS 
A. Microneedle Fabrication 
The microneedle arrays were fabricated using a 
combination of potassium hydroxide (KOH) wet etching and 
DRIE dry etching techniques [11-13]. Briefly, the starting 
material is a boron doped, 100 mm diameter monocrystalline 
silicon wafer, orientated in the <100> direction and onto 
which square oxide/nitride masks have been patterned using 
standard photolithography tools. These masks are aligned 
with the <110> crystal direction and the height of the 
subsequent microneedle is a linear function of the mask 
square side length. 
The patterned silicon wafer is then etched in a 29 % w/v 
aqueous KOH solution until convex corner mask undercut 
takes place, the eight planes intersect and a needle shape is 
formed. This needle is comprised of eight {263} planes, a 
base of {212} planes and has a height:base diameter aspect 
ratio of 3:2. Tip sharpness is a function of mask and crystal 
axis alignment accuracy; tip radii are typically of the order of 
50-100 nm. 
Following completion of the wet-etching step, a layer of 
aluminium is sputtered on the front side of the wafer to act as 
an etch stop, and capillary tubes are then micromachined 
from the back side of the wafer using a dry etching tool 
(SPTS Technologies, Newport, UK) incorporating SF6 and 
C4F8 etch chemistries. The resultant needle bore is 50 µm in 
diameter. The aluminium layer and masking layers are then 
stripped from both the front and back sides of the wafer, 
respectively. A scanning electron microscope image of a 500 
µm tall hollow microneedle is shown in Fig. 3.  
The octagonal microneedles are 500 µm tall, feature 71o 
sidewall angles, and have tip radii of the order of 50-100 nm. 
A microfluidic bore, 50 µm in diameter, is positioned at a 
lateral offset of 50 µm from the centre of the needle.  
 
Fig. 3. SEM of a 500 µm tall, ultrasharp hollow silicon microneedle. 
  
B. System Assembly 
 
Fig. 4.  A first prototype of the MicroTIPS sensor module. Electrical 
connections (yellow) to the impedance sensor are visible, as are the fluidic 
interface (blue) and the force sensor output. The microneedle array, with 
gold tracks for impedance monitoring, is at the centre of the system. 
A prototype assembly is shown in Fig. 4, which was 
constructed by first dicing microneedle wafers into 3 x 2 
arrays measuring 5.25 mm x 3.50 mm. Using shadow 
masking techniques, a 20 nm Ti/200 nm Au layer was 
patterned along each row to act as an impedance sensor. 
These arrays were bonded to a microfluidic reservoir, which 
was formed by first machining a cavity in a Perspex sheet; 
this was then bonded to a second sheet using double-sided 
pressure-sensitive adhesive tape. A flexible piezoresistive 
force sensor (‘Flexiforce’ A210, Tekscan Inc, Boston) was 
sandwiched between the two sheets to monitor the reservoir 
pressure. Electrical and fluidic interfaces were then added to 
the system, which is 7.5 mm thick and measures 21mm x 15 
mm.  
C. Experimental Procedure 
Following protocols approved by the Clinical Research 
Ethics Committee of the Cork Teaching Hospitals (CREC), 
human skin was excised following plastic surgical operations 
and stored at -80 oC until needed. It was defrosted, trimmed 
of excess fat, cut into squares of approximately 3 cm x 3 cm, 
and mounted on an artificial wound closure pad to mimic the 
mechanical properties of underlying tissue. 
Spring-loaded applicators are often used to apply 
microneedle devices to the skin in a consistent manner [14]. 
In this case, a custom-built, spring-loaded applicator, with 
impact energy of approximately 0.15 J/cm2, was used to 
ensure repeatable and reliable skin penetration. The 
experimental setup is illustrated in Fig. 5.  
After application, a mass of 100 g was placed on the 
needle-reservoir assembly to ensure a secure microneedle-
skin interface. The resultant pressure (~ 3 kPa) is similar in 
magnitude to that applied by a typical ECG patch (~0.8 kPa) 
[15] and is required to ensure a secure microneedle-skin  
interface. Delivery was achieved using a syringe pump 
(Model KDS100, KD Scientific, MA, USA) and a solution 
of 1% w/v methylene blue dye was used as a model delivery 
solution. 
 
 
 
 
Fig. 5. Experimental setup, showing applicator, delivery module, skin 
sample and associated electronics. 
D. Data Recording 
To record pressure data, the Flexiforce force sensor was 
calibrated and interfaced to a signal conditioning circuit 
according to the manufacturer’s instructions. Output voltage 
was measured using an Agilent 34411A digital multimeter at 
a frequency of 20 Hz and recorded using a PC running 
Agilent BenchVue software.  
Impedance data was measured at 30 kHz using an 
Analog Devices AD5933 impedance converter system 
interfaced to an Arduino Uno/ATMega 328. 
III. RESULTS 
A. Sensor Impedance  
 
Fig. 6. Impedance profile as a function of application and removal. 
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Fig. 6 illustrates the impedance change before, during 
and after application of the sensor module to the skin using 
the customized applicator. A sharp drop is apparent upon 
skin insertion (t = 15 s), and the point of removal is similarly 
visible (t = 35 s).  
B. System Pressure 
Pressure characteristics during and after an infusion of 50 
µL at a flow rate of 3 mL/hr are shown in Fig. 7. An increase 
of pressure with delivery volume is evident; this tended to 
drop slightly after delivery was complete and then decay 
very slowly thereafter as the fluid diffused into the tissue. 
The peak pressure (around 140 kPa) is similar to other 
reported values [16]. 
The 100 g mass was removed from over the sensor 
module at t = 400 s. A sharp drop in pressure is immediately 
apparent; indicating a leak of fluid from the system. 
 
 
Fig. 7. Reservoir pressure as a function of infusion time. Note the sharp 
pressure drop at t = 400 s, indicating the presence of a leak at the 
microneedle-skin interface. Total delivery volume is 50µL at a flowrate of 
3 mL/hour. 
C. Skin Penetration and Delivery Validation 
Fig. 8 illustrates the site of insertion of a row of 
microneedles. The transient pores created by the needles are 
clearly visible, as is the methylene blue dye solution beneath 
the skin’s surface, confirming fluidic delivery to the region 
beneath the stratum corneum. 
 
Fig. 8. En face image of microneedle delivery site.  
IV. DISCUSSiON 
It is clear from our experimental work that a 
mechanically secure needle-skin interface is key to 
successful drug delivery. The high pressures evident during 
the delivery phase mean that fluid will easily leak without 
appropriate external forces being applied to the site to keep 
the microneedle array in place, and this will be a major 
consideration during development of the skin adhesive tapes 
that will be used to robustly adhere the device to the body. 
Our integrated impedance sensor will assist with monitoring 
of this interface quality, and future work will develop 
continuous skin insertion depth sensors instead of the initial 
binary in/out sensor presented here.  
Performance and integration may also be improved by 
further miniaturization and thinning of the module, which 
will reduce fluidic dead volume and facilitate easier 
integration with the platform. This is achievable in the first 
instance by employing smaller pressure sensors and a thinner 
fluidic housing fabricated using additive manufacturing 
tools..  
Future work will also continue to assess the microfluidic 
delivery performance envelope, to develop miniaturized 
electronics and micropumps, and to characterize the 
reliability of the system in an in-vivo, ambulatory setting. 
V. CONCLUSION 
For the first time, a microneedle-based transdermal 
delivery system featuring embedded performance monitoring 
sensors has been demonstrated. Using an ultrathin pressure 
sensor and a customized impedance sensor, we have shown 
that it is possible to simultaneously measure both the fluidic 
pressure of the delivery system and the quality of the 
microneedle-skin contact during the delivery phase. Typical 
delivery volumes are of the order of 50-150 µL at flowrates 
of a few mL/hour, resulting in peak pressures of 
approximately 140 kPa.  
The work represents an important step on the roadmap 
towards the realization of high-value Micro Transdermal 
Interface Platforms (MicroTIPs). 
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